Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Carmot Therapeutics
Carmot Therapeutics
Roche targets more than $3 billion in annual obesity sales
Reuters
Mon, 09/30/24 - 10:09 am
Roche
Carmot Therapeutics
obesity
diabetes
‘The trajectory is encouraging.’ Roche hopes obesity drug will show 25% weight loss one day
Fierce Biotech
Wed, 09/11/24 - 11:15 pm
Roche
obesity
CT-388
Carmot Therapeutics
Roche says it’ll move quickly with ‘differentiated’ obesity drugs
BioPharma Dive
Thu, 07/25/24 - 10:05 pm
Roche
obesity
Carmot Therapeutics
CT-388
CT-996
Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference
Reuters
Fri, 01/5/24 - 11:25 am
M&A
JPMHC 2024
AbbVie
AstraZeneca
Bristol Myers Squibb
Carmot Therapeutics
Eli Lilly
Roche joins obesity drug chase with $2.7B deal for startup Carmot
BioPharma Dive
Mon, 12/4/23 - 10:18 am
Roche
Carmot Therapeutics
weight loss
obesity
M&A
Playing in the Hot Obesity Market, Carmot Braves Chilly IPO Waters
BioSpace
Mon, 11/20/23 - 10:07 am
Carmot Therapeutics
obesity
IPOs